Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery
NCT06210165Recruiting
- Start
- Dec 2022
- Primary completion
- Jun 2024
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in postoperative pulmonary complications (PPC) and atelectasis (2 arms). Primary endpoint: Lung Function (FVC, FEV1, FEV1/FVC). Started Dec 2022; status: recruiting.
02
Drugs
Sugammadex
03
Conditions
postoperative pulmonary complications (PPC)atelectasis
Beyond the preview
Go deeper on NCT06210165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06210165.